SANA - Sana Biotechnology, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
6.35 -0.28 (-4.41%)	0.07 (1.17%)	0.01 (0.17%)	0.08 (1.34%)	-0.29 (-4.57%)	0.01 (0.17%)	-0.01 (-0.24%)	0.15 (2.54%)

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Market

Earnings & Ratios

Basic EPS:: -0.39
Diluted EPS:: -0.39
Basic P/E:: -15.5641
Diluted P/E:: -15.5641
RSI(14) 1m:: 47.29
VWAP:: 6.05
RVol:: 0.4119

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	5.84 +0.11 (+1.92%)	Oct 15 16:17
1m	Price increase 1m	5.84 +0.11 (+1.92%)	Oct 15 16:17
1m	Price increase 1m	5.84 +0.11 (+1.92%)	Oct 15 16:17
1m	Price increase 1m	5.84 +0.11 (+1.92%)	Oct 15 16:17
1m	Price increase 1m	5.84 +0.11 (+1.92%)	Oct 15 16:17